CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Efficacy and toxicity of glivec in the treatment of gastrointestinal stromal tumours
DOI 10.1055/s-2006-943508
Bibliografische Angaben
Nachweis in CareLit
Autor:innenK Tamas, Z Papai, E Vegh, Á Petrányi, Z Szucs, Z Arányi, G Bodoky
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe06/2006
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Introduction/Study purpose: Gatrointestinal stromal tumours (GIST) were practically radio- chemotherapy resistant type of tumours, the median overall survival of advanced disease was 1 year in the past. GIST is characterized by C-KIT mutation specified by CD117 expression. Glivec (Imatinib Mesylate) is a selective inhibitor of the mutated C-KIT function. The purpose of our study was to assess efficacy and toxicity o…
Zitieren
Zitierempfehlung
K Tamas, Z Papai, E Vegh, Á Petrányi, Z Szucs, Z Arányi, G Bodoky (2006) Efficacy and toxicity of glivec in the treatment of gastrointestinal stromal tumours. Zeitschrift für Gastroenterologie (06). https://doi.org/10.1055/s-2006-943508
Mit CareLit weiterarbeiten